BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29078377)

  • 41. Cdc42 is an antihypertrophic molecular switch in the mouse heart.
    Maillet M; Lynch JM; Sanna B; York AJ; Zheng Y; Molkentin JD
    J Clin Invest; 2009 Oct; 119(10):3079-88. PubMed ID: 19741299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of β-adrenergic-stimulated phosphorylation of CaV1.2 channels on Ser1700 leads to heart failure.
    Yang L; Dai DF; Yuan C; Westenbroek RE; Yu H; West N; de la Iglesia HO; Catterall WA
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7976-E7985. PubMed ID: 27864509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
    Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.
    Appari M; Breitbart A; Brandes F; Szaroszyk M; Froese N; Korf-Klingebiel M; Mohammadi MM; Grund A; Scharf GM; Wang H; Zwadlo C; Fraccarollo D; Schrameck U; Nemer M; Wong GW; Katus HA; Wollert KC; Müller OJ; Bauersachs J; Heineke J
    Circ Res; 2017 Jan; 120(1):66-77. PubMed ID: 27821723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CXCR4 gene transfer prevents pressure overload induced heart failure.
    Larocca TJ; Jeong D; Kohlbrenner E; Lee A; Chen J; Hajjar RJ; Tarzami ST
    J Mol Cell Cardiol; 2012 Aug; 53(2):223-32. PubMed ID: 22668785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy.
    Oceandy D; Pickard A; Prehar S; Zi M; Mohamed TM; Stanley PJ; Baudoin-Stanley F; Nadif R; Tommasi S; Pfeifer GP; Armesilla AL; Cartwright EJ; Neyses L
    Circulation; 2009 Aug; 120(7):607-16. PubMed ID: 19652091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
    Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
    J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.
    Gold JI; Gao E; Shang X; Premont RT; Koch WJ
    Circ Res; 2012 Sep; 111(8):1048-53. PubMed ID: 22859683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.
    De Windt LJ; Lim HW; Haq S; Force T; Molkentin JD
    J Biol Chem; 2000 May; 275(18):13571-9. PubMed ID: 10788473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Caveolin 3-dependent loss of t-tubular I
    Bryant SM; Kong CHT; Watson JJ; Gadeberg HC; James AF; Cannell MB; Orchard CH
    Exp Physiol; 2018 May; 103(5):652-665. PubMed ID: 29473235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy.
    Bai Y; Zhang X; Li Y; Qi F; Liu C; Ai X; Tang M; Szeto C; Gao E; Hua X; Xie M; Wang X; Tian Y; Chen Y; Huang G; Zhang J; Xiao W; Zhang L; Liu X; Yang Q; Houser SR; Chen X
    Circ Res; 2024 Feb; 134(4):393-410. PubMed ID: 38275112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.
    Xu X; Hua Y; Nair S; Bucala R; Ren J
    Hypertension; 2014 Mar; 63(3):490-9. PubMed ID: 24366076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Acín-Pérez R; Cogliati S; López-Olañeta M; Ortiz-Sánchez P; Bonzón-Kulichenko E; Vázquez J; García-Pavía P; Rosenthal N; Enríquez JA; Lara-Pezzi E
    J Am Coll Cardiol; 2018 Feb; 71(6):654-667. PubMed ID: 29420962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.